An Updated Meta-Analysis of DOACs vs. VKAs in Atrial Fibrillation Patients With Bioprosthetic Heart Valve

BACKGROUND: Current guidelines recommend the utilization of direct-acting oral anticoagulants (DOACs) in patients with non-valvular atrial fibrillation (AF). However, the optimal anticoagulation strategy for AF patients with bioprosthetic heart valves (BPHV) remains controversial. Therefore, we cond...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Yalin, Zheng, Yuxiang, Li, Siyuan, Liu, Fuwei, Xue, Zhengbiao, Yin, Kang, Luo, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248967/
https://www.ncbi.nlm.nih.gov/pubmed/35783817
http://dx.doi.org/10.3389/fcvm.2022.899906

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248967/
https://www.ncbi.nlm.nih.gov/pubmed/35783817
http://dx.doi.org/10.3389/fcvm.2022.899906

Ejemplares similares